A few words from HTDS President, Terry Yuan

Terry Yuan, HTDS President, stated, "In the view of recent variation of our earnings and sales results, we feel that to present a better quality of disclosure we are obliged to offer earnings guidance to our shareholders for 2009. We recognize that the bulky nature of our sales and our research results may be distracting to some, and we offer this guidance in order for the investors to forget short-term, quarter-to-quarter variations, and start focusing on the long-term success. We hope this will be a one-time event, as we would rather have the company focused on its long-term development, which, as many can see, is unusually promising.

Mr. Yuan said further "Despite the soft world economy and the fact that many of the developing countries we market our products in are under economic strain, we still expect 2010 results to show rapid growth. We expect to grow due fact that the vaccines are a highly dynamic medical market at the present moment and we expect this trend to continue. Over four million children die each year needlessly, as they could have been saved by a simple and cheap vaccination, and that's where we come in." Mr. Yuan said. "Our focus, as always, is on ensuring we have sufficient products to meet our customers' needs, both today and in the future. We will continue to invest in worldwide marketing, but it is also important to understand the major significance of our medical research results."

Best Damn Penny Stocks, a leading financial publication, is pleased to alert investors of stocks on the move. Sign Up for our Free Stock Newsletter